Immunotherapy for glioblastoma: the devil is in... [J Clin Oncol. 2011] - PubMed

Save items

loading

Related citations in PubMed

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. [J Clin Oncol. 2010]
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Sampson JH, Heimberger AB, Archer GE, Aldape KD, Friedman AH, Friedman HS, Gilbert MR, Herndon JE 2nd, McLendon RE, Mitchell DA, et al. J Clin Oncol. 2010 Nov 1; 28(31):4722-9. Epub 2010 Oct 4.
Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events. [J Clin Oncol. 2010]
Cancer vaccines in glioma: how to balance the challenges of small trials, efficiency, and potential adverse events.
Lowenstein PR. J Clin Oncol. 2010 Nov 1; 28(31):4670-3. Epub 2010 Oct 4.
[Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma]. [Cancer Radiother. 2011]
[Benefit of a prolonged adjuvant treatment with temozolomide for the management of patients with glioblastoma].
Malkoun N, Fotso MJ, Cartier L, Forest F, Auberdiac P, Chargari C, Thorin J, Pacaut C, Peoc'h M, Nuti C, et al. Cancer Radiother. 2011 Jun; 15(3):202-7. Epub 2011 Mar 30.
Review Chemotherapy for malignant gliomas. [Wien Med Wochenschr. 2006]
Review Chemotherapy for malignant gliomas.
Marosi C. Wien Med Wochenschr. 2006 Jun; 156(11-12):346-50.
Review The evolution of chemoradiation for glioblastoma: a modern success story. [Curr Oncol Rep. 2006]
Review The evolution of chemoradiation for glioblastoma: a modern success story.
Mirimanoff RO. Curr Oncol Rep. 2006 Jan; 8(1):50-3.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Immunotherapy for glioblastoma: the devil is in the details.
Immunotherapy for glioblastoma: the devil is in the details.
J Clin Oncol. 2011 Aug 1 ;29(22):3105; author reply 3105-6. doi: 10.1200/JCO.2011.34.9019. Epub 2011 Jun 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Immunotherapy for glioblastoma: the devil is in the details.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information